Colín SVG, Alva ANV, Morineau CC, Athié GJM

Language: Spanish
References: 11
Page: 194-197
PDF size: 529.45 Kb.

ABSTRACT

Spinal anesthesia is one of the most used anesthetic techniques in clinical practice, it consists of administering local anesthetic in the subarachnoid space. The use of ropivacaine has an onset of action of 10 to 15 minutes, with a longer duration of the anesthetic and analgesic effect, with a decrease in motor blockade. Due to the limited evidence described, we decide to investigate the experience of subarachnoid anesthesia in surgery, and evaluate the duration of motor and sensory blockade. The design of this study was retrospective, observational, descriptive, cross-sectional, reviewing records at a single center (Hospital Angeles Mocel) between March- December 2024. A sample of 49 patients was taken, describing the duration of motor and sensory block, hemodynamic changes in transanesthetic. It was found that the average motor time was 377 minutes and sensory time was 298.4 minutes, we found that ropivacaine produced a shorter duration of motor block but a longer duration of sensory block. The use of ropivacaine in the intrathecal space is considered a safe and effective technique, with a better prognosis for the patient.

REFERENCES

1. Panni MK, George RB, Allen TK, Olufolabi AJ, Schultz JR, Okumura Met al. Minimum effective dose of spinal ropivacaine with and withoutfentanyl for postpartum tubal ligation. Int J Obstet Anesth. 2010; 19(4): 390-394.

2. Hinojosa-Sánchez O, Alamilla-Beltrán I, Han-Alonso R, Solano-Moreno H, Alvarez-Villaseñor AS, Ramírez-Contreras JP et al. Bloqueoraquídeo subaracnoideo con ropivacaína versus bupivacaína isobáricaen cirugía urológica y ortopédica. Rev Med Inst Mex Seguro Soc. 2009;47 (5): 539-544.

3. González-Grosso NG, Labrada A, Santana JE. Bloqueo epidural conropivacaína en la insuficiencia arterial crónica de miembros inferiores:ensayo clínico. Rev Soc Esp Dolor. 2015; 12 (2): 86-92.

4. Marrón-Peña M, Rivera-Flores J. Ropivacaína neuroaxial paraoperación cesárea. Rev Mex Anest. 2008; 31 (2): 133-138.

5. Sanli S, Yegin A, Kayacan N, Yilmaz M, Coskunfirat N, Karsli B. Effectsof hyperbaric spinal ropivacaine for caesarean section: with or withoutfentanyl. Eur J Anaesthesiol. 2005; 22 (6): 457-461. doi: 10.1017/s0265021505000785.

6. Marrón PM, Rivera FJ. Ropivacaína subaracnoidea en cesárea. BoletínSMAGO. 2006; 3: 4-5.

7. Ávila LA, Chavéz JR. Anestesia espinal con dexmedetomidina másropivacaína 0.75% vs ropivacaína 0.75%. Rev Anest Méx (Supl). 2005:439.

8. Scott DB, Lee A, Fagan D, Bowler GM, Bloomfield P, Lundh R. Acutetoxicity of ropivacaine compared with that of bupivacaine. AnesthAnalg. 1989; 69 (5): 563-569.

9. González-Vásquez M, Calderon N, Metz G, Szwarc M. Anestesiasubaracnoidea con ropivacaína hiperbárica versus bupivacaínahiperbárica asociadas a fentanilo para operación cesárea de urgencia:ensayo clínico controlado con asignación aleatoria. Anest AnalgReanim. 2013; 26 (1): 4.

10. Guillermo-Santiago R, Posi G, Ogas M, Dicuatro N, González-Vélez M.Uso comparativo de bupivacaína vs ropivacaína peridural asociados afentanilo en cesárea. Rev Arg Anestesiol. 2002; 60 (4): 209-226.

11. Lacassie QH, de La Cuadra FJC, Kychenthal LC, Irarrázaval MMJ,Altermatt CFR. Anestesia espinal. Parte II: Importancia de la anatomía,indicaciones y drogas más usadas. Rev Chil Anest. 2021; 50 (2): 398-407.